Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

NCT01081730 · clinicaltrials.gov ↗

COMPLETED

Status

2040

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: anti-TNF biologics
OTHER: general population
BIOLOGICAL: non-anti-TNF biologics
BIOLOGICAL: ustekinumab
DRUG: systemic non-biological treatments

Sponsor

Janssen Biotech, Inc.